Our News Archive 2015
Are you searching for 2015's press releases?
Dear User,
Check our overview for press releases that have been published in 2015.
To get press releases published before 2014, please send an email to service@emdgroup.com.
All Merck KGaA, Darmstadt, Germany, press releases are distributed by e-mail at the same time they become available on the EMD Group Website. In case you are a resident of the USA or Canada please go to www.emdgroup.com/subscribe to register for your online subscription of this service as our geo-targeting requires new links in the email. You may later change your selection or discontinue this service.
About Merck KGaA, Darmstadt, Germany
Merck KGaA, Darmstadt, Germany, a leading science and technology company, operates across healthcare, life science and electronics. Around 60,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From advancing gene editing technologies and discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2021, Merck KGaA, Darmstadt, Germany, generated sales of € 19.7 billion in 66 countries.
The company holds the global rights to the name and trademark “Merck” internationally. The only exceptions are the United States and Canada, where the business sectors of Merck KGaA, Darmstadt, Germany operate as EMD Serono in healthcare, MilliporeSigma in life science, and EMD Electronics. Since its founding in 1668, scientific exploration and responsible entrepreneurship have been key to the company’s technological and scientific advances. To this day, the founding family remains the majority owner of the publicly listed company.
2015
- 30.01.2015 Merck KGaA, Darmstadt, Germany Announces Personnel Changes in Finance Function
- News: Personnel-Changes-Finance-EN.pdf
- Images: Werth_13.jpg, Stickler_12.jpg
- 28.01.2015 MilliporeSigma Introduces New High-Performance Water Purification Systems with 24/7 Real-Time Monitoring and Remote Control
- 15.01.2015 Merck KGaA, Darmstadt, Germany Presents Liquid Crystal Window Technology at BAU 2015
- 14.01.2015 Merck KGaA, Darmstadt, Germany Positions itself with New Suprima® Quality Brand for High-Quality Effect Pigments
- 30.01.2015 Merck KGaA, Darmstadt, Germany Announces Personnel Changes in Finance Function
- 24.02.2015 Ralph R. Dammel from Merck KGaA, Darmstadt, Germany receives the Frits Zernike Award for Microlithography at SPIE 2015
- 20.02.2015 EMD Serono and Sysmex Inostics Announce First Liquid Biopsy RAS Biomarker Testing Center Opens: Important Milestone for mCRC Patients
- News: RAS-Biomarker-Testing-EN.pdf
- Image: SysmexmachinPR.png
- 18.02.2015 Merck KGaA, Darmstadt, Germany presents next-generation lithography and patterning solutions at SPIE 2015
- 13.02.2015 Merck KGaA, Darmstadt, Germany Strengthens Presence as Leading Oncology Company by Taking Full Promotional Responsibility for Erbitux in Japan
- News: Erbitux-Japan-EN.pdf
- Images: Erbitux_Antibody.png, ElcinErgun.jpg, BelenGarijo.jpg
- 11.02.2015 Merck KGaA, Darmstadt, Germany and FlexEnable take major step forward in Plastic Liquid Crystal Display technology
- 02.02.2015 MilliporeSigma Announces Agreement with Precision Biologics, Inc. to Provide Upstream Process Development Services
- 02.02.2015 Merck KGaA, Darmstadt, Germany Repatriates Diabetes and Thyroids Portfolio in Russia to Continue to Drive Emerging Markets Strategy
- 31.03.2015 Innovations and Concepts with Added Value: Merck KGaA, Darmstadt, Germany at the in-cosmetics 2015 Trade Show
- 30.03.2015 EMD Serono and Intrexon Announce Agreement for the Development and Commercialization of CAR-T Therapy
- News: CAR-T-Therapy-EN.pdf
- 22.03.2015 Merck KGaA, Darmstadt, Germany Wins 2015 German Industry Innovation Award
- 21.03.2015 Merck KGaA, Darmstadt, Germany Supports Schistosomiasis Education in Mozambique
- News: Schistosomiasis-Education-EN.pdf
- Image: Bilharziose_1.jpg
- 17.03.2015 Merck KGaA, Darmstadt, Germany Places U.S. Bond Amounting to US$ 4.0 Billion
- News: Bond-EN.pdf
- Image: Kuhnert.jpg
- 10.03.2015 EMD Serono and Illumina Enter Strategic Collaboration for Diagnostics in Oncology
- News: Illumina-EN.pdf
- Image: Sue_Herbert.jpg
- 09.03.2015 EMD Serono and Opexa Amend Agreement to Support Ongoing Development of Tcelna (imilecleucel-T) for Multiple Sclerosis
- 04.03.2015 Merck KGaA, Darmstadt, Germany Employees Benefit From Company Success
- News: Company-Success-EN.pdf
- Image: Beckmann.jpg
- 03.03.2015 Merck KGaA, Darmstadt, Germany Finishes Year of Key Strategic Moves with Record Figures
- News: Key-Strategic-Moves-EN.pdf
- Image: Kley.jpg
- 30.04.2015 Paul T. Anastas Awarded Emanuel Merck Lectureship 2015
- News: Paul-Anastas-Awarded-EN.pdf
- Image: EML_Paul_Anastas.jpg
- 27.04.2015 MilliporeSigma Introduces Magna ChIRP™ RNA Interactome Kits for the Analysis of Chromatin-Associated RNAs
- News: Magna-ChIRP-RNA-EN.pdf
- 25.04.2015 Merck KGaA, Darmstadt, Germany Wins German Innovation Award with Liquid Crystals
- 20.04.2015 Global Strategic Partners Merck KGaA, Darmstadt, Germany and Pfizer Initiate Phase III Study with Avelumab in Patients with Stage IIIb/IV Non-Small Cell Lung Cancer
- News: Study-Avelumab-EN.pdf
- Image: Immuno-Oncology_AntiTumor.jpg
- 20.04.2015 Merck KGaA, Darmstadt, Germany Demonstrates Commitment to Corporate Responsibility
- News: Commitment-Corporate-Responsibility-EN.pdf
- Image: Titelbild.jpg
- 17.04.2015 Annual General Meeting Approves Dividend Increase
- News: Approves-Dividend-Increase-EN.pdf
- Image: HV_2015.jpg
- 17.04.2015 Merck KGaA, Darmstadt, Germany Proposes Dividend Increase to AGM After a Year of
Key Strategic Moves – Foundation Set for Further Organic Growth- News: Further-Organic-Growth-EN.pdf
- Image: Aktie.jpg
- 16.04.2015 Alise Reicin Joins EMD Serono as Head of Global Clinical Development
- News: Reicin-Joins-Clinical-EN.pdf
- Image: AlisePicture.jpg
- 15.04.2015 EMD Serono’s Saizen Liquid can now be Stored up to one Week at Room Temperature
- News: Saizen-Liquid-EN.pdf
- 15.04.2015 “Living Innovation”: Merck KGaA, Darmstadt, Germany at the European Coatings Show 2015
- 13.04.2015 Merck KGaA, Darmstadt, Germany Appoints Udit Batra to Head Combined Life Science Business Following Pending Sigma-Aldrich Acquisition
- News: Udit-Batra-Head-Combined-EN.pdf
- Image: Udit_Batra.jpg
- 07.04.2015 Global Strategic Partners Merck KGaA, Darmstadt, Germany and Pfizer Finalize Agreement to Co-Promote XALKORI® (crizotinib)
- 01.04.2015 EMD Serono and Medicines for Malaria Venture Sign Agreement to Develop Potential Antimalarial Therapy
- 30.04.2015 Paul T. Anastas Awarded Emanuel Merck Lectureship 2015
- 28.05.2015 Merck KGaA, Darmstadt, Germany Inaugurates OLED Application Center (OAC) in Korea
- 28.05.2015 EMD Serono as Pioneer in Assisted Reproductive Treatments Takes Leading Role in Fertility Technologies Signing a Global Collaboration Agreement with Genea Biomedx
- News: Fertility-Technologies-Signing-EN.pdf
- Image: GERIFront2.png
- 26.05.2015 EMD Serono supports 7th International Thyroid Awareness Week to Unmask Hypothyroidism
- News: Thyroid-Awareness-Week-EN.pdf
- Image: Logo1.JPG
- 22.05.2015 Merck KGaA, Darmstadt, Germany Leads European Research Consortium on Printed Electronics
- 22.05.2015 EMD Serono Announces CHMP Positive Opinion to Extend Kuvan Use to Children with PKU Below 4 Years of Age
- News: Opinion-Extend-EN.pdf
- 21.05.2015 MilliporeSigma Enters Into Agreement to Acquire Exclusive Rights to Singulex’s Ultra-Sensitive Single Molecule Counting (SMC™) Technology
- News: Singulex-EN.pdf
- 21.05.2015 MilliporeSigma Introduces Single-Pass Tangential Flow Filtration with Pellicon® Cassettes for Increased Capacity, Recovery and Concentration
- News: Single-Pass-EN.pdf
- 20.05.2015 For Displays and More: Merck KGaA, Darmstadt, Germany Presents Expanded Portfolio and New Developments at SID Display Week 2015
- 19.05.2015 Merck KGaA, Darmstadt, Germany Starts a Challenging 2015 with a Solid First Quarter
- News: 2015-05-19-Q1-Press-Release-EN.pdf
- Image: Kley.jpg
- 15.05.2015 Merck KGaA, Darmstadt, Germany to Present Data at ASCO that Illustrate How the Company is Tackling Difficult-to-Treat Cancers
- News: Difficult-to-Treat-Cancers-EN.pdf
- Image: chicago-55113.jpg
- 13.05.2015 Merck KGaA, Darmstadt, Germany and Pfizer to Present Data at ASCO for Avelumab, an Investigational Anti-PD-L1 Antibody
- News: Anti-PD-L1-Antibody-EN.pdf
- Image: iOnc.jpg
- 12.05.2015 Merck KGaA, Darmstadt, Germany Receives FDA Fast Track Designation for Evofosfamide for Treatment of Patients Living With Advanced Pancreatic Cancer
- News: FDA-Fast-Track-EN.pdf
- Image: PancreaticCancer_1a.jpg
- 11.05.2015 Revolution in Rotomolding: Merck KGaA, Darmstadt, Germany Develops Iriodin® RMP for Enhancing Decorative Rotational Molded Products
- News: Iriodin-RMP-EN.pdf
- 07.05.2015 Merck KGaA, Darmstadt, Germany Presents Organic Photovoltaic Materials at EXPO 2015 in Milan
- 06.05.2015 Study Finds MilliporeSigma’s Strat-M® Synthetic Membrane Comparable to Human and Animal Skin for Permeation Studies
- News: Strat-M-EN.pdf
- 30.06.2015 EMD Serono Introduces New Eeva Test Version Aiming for Optimized Assisted Reproductive Outcomes
- 29.06.2015 Merck KGaA, Darmstadt, Germany To Fully Acquire Israeli Quantum Materials Company
Qlight Nanotech - 23.06.2015 Merck KGaA, Darmstadt, Germany Launches “More than a Mother” Campaign Aiming to Reduce Social Suffering of Infertile Women in Africa
- 22.06.2015 EMD Serono’s MSdialog Wins Readers Choice Category of 2015 Medical Design Excellence Award (MDEA)
- 19.06.2015 Merck KGaA, Darmstadt, Germany Invests € 30 Million in New OLED Production Plant in Darmstadt
- 17.06.2015 Innovative Laser Pigments: Merck KGaA, Darmstadt, Germany at the Laser World of Photonics 2015
- 17.06.2015 EMD Serono Commits € 1.2 million to the Grant for Fertility Innovation (GFI) for 2015 / 16
- 16.06.2015 MilliporeSigma’s Additions to the MAS-100® Product Family of Microbial Air Samplers Deliver Improved Functionality for Pharmaceutical Manufacturers
- 15.06.2015 Merck KGaA, Darmstadt, Germany’s Acquisition of Sigma-Aldrich Receives Clearance from EU Regulators – Approvals Also Granted by Japan and China
- 15.06.2015 MilliporeSigma Expands Provantage® Biodevelopment Services with Addition of Provantage® Clone Generation Service
- 15.06.2015 MilliporeSigma Introduces the Mobius® 2000 Liter Single-Use Bioreactor with Industry-leading Design for Ease-of-Use
- News: Bioreactor-Design-EN.pdf
- Image: Bioreactor_2.jpg
- 14.06.2015 EMD Serono: Innovative Fertility Technologies Gavi and Geri of Partner Genea Biomedx Receive CE Mark
- News: Gavi-Geri-EN.pdf
- Image: Gavi_Cad_Pic.jpg
- 11.06.2015 EMD Serono Wins Two Red Dot Design Awards 2015 for High Quality Design of Fertility Pens
- News: Red-Dot-Design-Award-EN.pdf
- Image: Gonal-f_Pen.jpg
- 09.06.2015 Consumerization Drives Growth at Merck KGaA, Darmstadt, Germany Consumer Health
- 08.06.2015 Merck KGaA, Darmstadt, Germany, Illumina and Genea Form the Global Fertility Alliance for Excellence in Assisted Reproductive Treatment
- 02.06.2015 MilliporeSigma Introduces Compaction Technology to Improve Solubility and Facilitate Handling of Cell Culture Media Used in Biopharmaceutical Production
- 02.06.2015 Merck KGaA, Darmstadt, Germany Wins 2015 Display Industry Award with Liquid Crystals
- 01.06.2015 MilliporeSigma Congratulates Nancy Hopkins, Ph.D. of the Koch Institute for Integrative Cancer Research (MIT) as Recipient of 2015 Alice C. Evans Award
- News: Alice-Evans-Award-EN.pdf
- 01.06.2015 MilliporeSigma Launches CellventoTM CHO Cell Culture Media Platform for Optimized Cell Growth and Productivity
- 30.07.2015 Merck KGaA, Darmstadt, Germany Announces Application Period for Start-ups
- 30.07.2015 Merck KGaA, Darmstadt, Germany Appoints Isabel De Paoli as new Head of Group Communications
- News: Isabel-De-Paoli-Communications-EN.pdf
- Images: DePaoli.jpg, HeikoSchoen.jpg
- 23.07.2015 MilliporeSigma Adds Protein Pegylation to Portfolio of Services for Biopharmaceutical Industry through Collaboration with celares GmbH
- 21.07.2015 EMD Serono Awards € 20,000 to Innovation Cup Winners
- 20.07.2015 Merck KGaA, Darmstadt, Germany Receives EU-Approval to Extend Kuvan Use to Children with PKU Below 4 Years of Age
- News: EU-Approval-Extend-Kuvan-EN.pdf
- Image: Kuvan-191.jpg
- 15.07.2015 13th "Premio Letterario Merck KGaA, Darmstadt, Germany" Honors Authors for Creating Bridges Between Science and Literature
- News: Bridges-Science-Literature-EN.pdf
- Image: PremioLetterario.jpg
- 10.07.2015 Johann Heinrich Merck KGaA, Darmstadt, Germany Award 2015 Goes to Gabriele Goettle
- 27.08.2015 Merck KGaA, Darmstadt, Germany Accelerator Program Participants Selected
- 27.08.2015 Merck KGaA, Darmstadt, Germany Places Euro Bonds Amounting to € 2.1 Billion
- News: Euro-Bonds-EN.pdf
- Image: Kuhnert.jpg
- 14.08.2015 Galactic Sparkle: The New Miraval® Cosmic Pigment Range from Merck KGaA, Darmstadt, Germany
- 12.08.2015 MilliporeSigma Announces Charitable Contribution to Massachusetts Institute of Technology (MIT) for Development of Novel Ebola Diagnostic and Tracking Platform
- 11.08.2015 Merck KGaA, Darmstadt, Germany Secures All Antitrust Approvals for Sigma-Aldrich Acquisition
- 06.08.2015 Merck KGaA, Darmstadt, Germany Reports Sales and Earnings Growth in Q2 2015
- News: 2015-08-06-Q2-Press-Release-EN.pdf
- Image: Kley.jpg
- 03.08.2015 Merck KGaA, Darmstadt, Germany and Nano-C Present Enhanced Materials for Organic Photovoltaics
- 30.09.2015 Merck KGaA, Darmstadt, Germany’s Consumer Health Business Counts on Latin America for Growth
- 28.09.2015 MilliporeSigma Publishes White Paper Highlighting Importance of Emerging Biotech Companies for Discovery of New Drugs During Recent Emerging Biotech Executive Summit
- News: Emerging-Biotech-Companies-EN.pdf
- Image: Udit_Batra.jpg
- 28.09.2015 Merck KGaA, Darmstadt, Germany Progresses Toward Completion of Sigma-Aldrich Acquisition
- News: Sigma-Aldrich-Acquisition-EN.pdf
- Image: BerndReckmann.jpg
- 26.09.2015 Merck KGaA, Darmstadt, Germany Rewards Pioneering Researchers with €1 Million Through Grant for Oncology Innovation Initiative
- 25.09.2015 Merck KGaA, Darmstadt, Germany and Pfizer Announce FDA Orphan Drug Designation for Investigational Immunotherapy Avelumab in Merkel Cell Carcinoma
- 24.09.2015 Merck KGaA, Darmstadt, Germany and Pfizer Collaborate with Dako, an Agilent Technologies Company, on Development of Companion Diagnostic for Investigational anti-PD-L1 Antibody, Avelumab
- News: Development-Companion-Diagnostic-EN.pdf
- Image: About.jpg
- 24.09.2015 New Rebif® (interferon beta-1a) Data at ECTRIMS Highlights the Importance of Disability and Imaging Predictors for Long Term Outcomes
- 21.09.2015 New Depth with Xirallic® NXT Tigris Blue from Merck KGaA, Darmstadt, Germany
- 18.09.2015 Merck KGaA, Darmstadt, Germany and Tridonic Enter Into License Agreement for White LEDs
- 16.09.2015 Merck KGaA, Darmstadt, Germany Launches Partnership with Department of Health and Philippine Thyroid Association
- News: Philippine-Thyroid-Association-EN.pdf
- Image: TIM_3247.JPG
- 15.09.2015 Merck KGaA, Darmstadt, Germany Streamlines Healthcare Management as Business Enters New Strategic Phase
- 14.09.2015 MilliporeSigma Introduces Enhancements to its EMPROVE® Program of Pharmaceutical Raw Materials to Facilitate Risk Assessment
- News: EMPROVE-Program-EN.pdf
- 11.09.2015 Merck KGaA, Darmstadt, Germany and Pfizer to Present Updates for Avelumab at the European Cancer Congress 2015
- 11.09.2015 Merck KGaA, Darmstadt, Germany Intends to Submit Cladribine Tablets to Treat Multiple Sclerosis for Registration in Europe
- News: Cladribine-Registration-Europe-EN.pdf
- Image: neuron.jpg
- 11.09.2015 EMD Serono Expands Biopharmaceutical R&D Facility to Accelerate Innovation at Darmstadt Headquarters
- 11.09.2015 Merck KGaA, Darmstadt, Germany To Present New Data at the European Cancer Congress 2015 Reinforcing the Company’s Patient-Centric Focus
- 03.09.2015 Heinrich Emanuel Merck KGaA, Darmstadt, Germany Award 2015 Granted to Professor Petra Dittrich
- News: EM2015-Dittrich-EN.pdf
- Image: Prof_Petra_Dittrich.jpg
- 26.10.2015 MilliporeSigma Introduces Parteck® SRP 80 Excipient for Sustained-Release Oral Solid Dose Formulations
- 23.10.2015 Merck KGaA, Darmstadt, Germany receives 2015 European Human Growth Hormone Competitive Strategy Innovation and Leadership Award
- News: Frost-Sullivan-Award-EN.pdf
- Image: Simon_Sturge.jpg
- 22.10.2015 MilliporeSigma to Provide Provantage® End-to-End Solution for Development and Manufacture of Biosimilars under Strategic Alliance with Turgut Ilaç
- 21.10.2015 MilliporeSigma Introduces Millipore Express® PHF Hydrophilic Sterilizing-Grade Filters for Fast, Efficient and Economical Buffer Filtration
- 20.10.2015 Merck KGaA, Darmstadt, Germany Announces Sigma-Aldrich Business Sale to Honeywell to Fulfill EU Commitments
- 14.10.2015 Merck KGaA, Darmstadt, Germany Brand Relaunched
- 13.10.2015 Stefan Oschmann Appointed New Executive Board Chairman of Merck KGaA, Darmstadt, Germany
- 08.10.2015 EMD Serono Announces Recipients of the Third Annual €1 Million Grant for Multiple Sclerosis Innovation
- 07.10.2015 Merck KGaA, Darmstadt, Germany and Pfizer Announce Investigational Immunotherapy Avelumab Receives FDA Fast Track Designation for Metastatic Merkel Cell Carcinoma
- News: Investigational-Immunotherapy-ENg.pdf
- Image: Home-Carousel-2.jpg
- 03.10.2015 EMD Serono Awards Grant for Growth Innovation at ESPE in Barcelona
- News: ESPE-EN.pdf
- Image: Winners.jpg
- 01.10.2015 Merck KGaA, Darmstadt, Germany Agrees to Return Kuvan Rights to BioMarin Pharmaceutical to Strengthen Focus on Core Business
- News: Return-Kuvan-Rights-EN.pdf
- Image: Pack_Kuvan.jpg
- 01.10.2015 Merck KGaA, Darmstadt, Germany Creates Greater Scope for Developing Ideas – Innovation Center opened
- 01.10.2015 Merck KGaA, Darmstadt, Germany Presents Details on Immuno-Oncology Program Including First-in-Man Milestone with Investigational Bi-Functional Immunotherapy
- 26.10.2015 MilliporeSigma Introduces Parteck® SRP 80 Excipient for Sustained-Release Oral Solid Dose Formulations
- 30.11.2015 Miraval® Cosmic Bronze – The Second Effect Pigment in the New Product Series from Merck KGaA, Darmstadt, Germany
- 26.11.2015 Gray Modules: New Dimension in Organic Photovoltaics for Buildings
- 25.11.2015 Merck KGaA, Darmstadt, Germany and Pfizer Receive Positive Opinion for Orphan Drug Designation for Avelumab in Merkel Cell Carcinoma from EMA Committee for Orphan Medicinal Products
- 20.11.2015 Merck KGaA, Darmstadt, Germany Counts on Africa for Growth
- 19.11.2015 Merck KGaA, Darmstadt, Germany and the University of Cape Town to Develop a Drug Discovery Platform for Malaria
- 18.11.2015 Merck KGaA, Darmstadt, Germany and Pfizer Receive FDA Breakthrough Therapy Designation for Avelumab in Metastatic Merkel Cell Carcinoma
- 18.11.2015 Merck KGaA, Darmstadt, Germany Completes Sigma-Aldrich Acquisition
- News: Sigma-Aldrich-Acquisition-EN.pdf
- Image: Mercrobe_man_v1.jpg
- 12.11.2015 Merck KGaA, Darmstadt, Germany Reports Jump in Earnings in Q3 2015
- News: 2015-11-12-Q3-Press-Release-EN.pdf
- Image: Kley.jpg
- 10.11.2015 Merck KGaA, Darmstadt, Germany Set to Complete Sigma-Aldrich Acquisition
- News: EU-Approva-Sigma-Aldrich-EN.pdf
- Image: TimesSquare_22Sep2014.jpg
- 06.11.2015 Merck KGaA, Darmstadt, Germany Recognized for Digital Workplace Platform
- News: EVA-Award-EN.pdf
- Image: Employee-Dashboard-PR.jpg
- 06.11.2015 Merck KGaA, Darmstadt, Germany Underscores Commitment to Equal Opportunity
- 05.11.2015 Karl-Ludwig Kley Joins Verizon Board of Directors
- News: Kley-Board-Directors-Verizon-EN.pdf
- Image: 11116HIGH_KLEY.JPG
- 05.11.2015 Merck KGaA, Darmstadt, Germany Introduces Spectroquant® Prove
- 04.11.2015 Merck KGaA, Darmstadt, Germany and Pfizer Announce Initiation of Phase III First-Line Trial of Avelumab in Patients with Recurrent or Stage IV Non-Small Cell Lung Cancer
- 04.11.2015 Merck KGaA, Darmstadt, Germany Hosts Hall of Fame of German Research for the First Time
- 03.11.2015 Merck KGaA, Darmstadt, Germany’s Glucophage® Extended Release (XR) Can be Used for More Type 2 Diabetes Patients
- News: Glucophage-Extended-Release-EN.pdf
- Image: Luciano_Rossetti.jpg
- 02.11.2015 Merck KGaA, Darmstadt, Germany Appoints Laszlo Radvanyi as Head of Global Immuno-Oncology Research
- 02.11.2015 Experts to Explore new Smart Materials at “Displaying Futures” Symposium
- 02.11.2015 Merck KGaA, Darmstadt, Germany and Selvita Announce Drug Discovery Collaboration
- 02.11.2015 Merck KGaA, Darmstadt, Germany Named as Top Employer by Science Magazine
- 22.12.2015 Merck KGaA, Darmstadt, Germany and Pfizer Advance Clinical Development Program with Two Additional Phase III Trials of Avelumab
- News: Trials-Avelumab-EN.pdf
- Images: Logo.JPG, MaceRothenberg_Pfizer.jpg
- 21.12.2015 Ronastar® Lapis Jewel – For Sparkling Deep Blue Cosmetics
- News: Ronastar-Lapis-Jewel-EN.pdf
- Image: gp_24.jpg
- 16.12.2015 Merck KGaA, Darmstadt, Germany Honored by R&D Magazine for Innovation
- 14.12.2015 Merck KGaA, Darmstadt, Germany Acquires Ormet Circuits
- News: Ormet-Circuits-EN.pdf
- Image: InnovationCenter_Logo.JPG
- 14.12.2015 Merck KGaA, Darmstadt, Germany Helps Refugees in Lebanon
- News: Helps-Refugees-Lebanon-EN.pdf
- Image: PMLibanon.jpg
- 10.12.2015 Merck KGaA, Darmstadt, Germany Confident for 2016
- News: Confident2016-EN.pdf
- Images: Kley.jpg, Mercrobe_man_v1.jpg
- 09.12.2015 Merck KGaA, Darmstadt, Germany and Pfizer Initiate Two Phase III Studies of Investigational Immunotherapy Avelumab in Advanced Gastric and Gastro-esophageal Junction Cancers
- 07.12.2015 Merck KGaA, Darmstadt, Germany Decides Not to Pursue Evofosfamide Further in Soft Tissue Sarcoma and Pancreatic Cancer
- News: Sarcoma-Pancreatic-Cancer-EN.pdf
- Image: PancreaticCancer_1a.jpg
- 22.12.2015 Merck KGaA, Darmstadt, Germany and Pfizer Advance Clinical Development Program with Two Additional Phase III Trials of Avelumab
Related News
-
Press Releases
Merck KGaA, Darmstadt, Germany, to Acquire US Biopharma Company SpringWorks ...
Merck KGaA, Darmstadt, Germany, and SpringWorks Therapeutics, have entered into a definitive agreement for us to acquire SpringWorks.
2025/04/28